mathematical concepts and sophisticated algorithmic methods can be integrated into bioinformatics pipelines, queries, and statistical and machine-learning tools needs further investigation. We believe that a secure privacy-preserving platform will encourage freer flow of data across silos and reduce complexities around patient consent and DUAs.
affected and the number of bytes transferred; and second, logging compute access for the user, event time, operation performed, API used to make the access, the resource modified (such as virtual machines, disks, firewalls, machine images and networks) and network traffic in bytes, including notes about whether traffic was between or within compute zones (North America, Europe, Asia-Pacific, China), ingress (to the cloud) or egress (from the cloud)
Logging and monitoring are typically not a requirement for non-PHI data, but we believe that to feel confident about the security implementation, these are a necessary step. Administrators should perform routine logging and mine the logs, using simple scripts or queries, for unexpected access patterns. We recommend the three following monitoring practices: first, as Google and other cloud providers send out security bulletins 18 with details of vulnerabilities and patches, we recommend that administrators monitor that researchers use OS images with the latest security patches; second, because even for a generally HIPAA-compliant cloud provider (e.g., GCP), beta service offerings are not covered by HIPAA, for IRB-guided studies requiring HIPAA compliance, administrators should either disallow service via quota or monitor for use; and third, we recommend that administrators stay informed regarding DUAs for especially sensitive projects to make sure there are no inadvertent violations.
Note that logging eventually results in data storage and hence cost. Administrators must keep track of these costs and plan for suitable strategies to manage log data volume.
Training. We recommend that users take basic HIPAA training to cover IT security, data access, and restrictions and responsibilities for working with sensitive patient information, irrespective of whether on-premise or cloud systems are used. If such a training is not mandated by the institute, the administrator should put together a basic IT training program around authentication, authorization and data protection guidelines for transferable media.
Administrators also require training. Cloud platforms have abstracted the underlying system administration requirements via high-level APIs and graphical user interfaces, thus removing the burden of understanding low-level system engineering. It is our experience that for an existing system administrator or IT-savvy informatics personnel, gaining familiarity with the cloud is relatively straightforward.
However, we believe that the administrator will need to dedicate time to stay up to date with rapidly evolving system management tools via annual trainings.
Security and privacy. Security is necessary but not sufficient for privacy. Security can be broken by large-scale transnational hacking efforts, occasional rogue behavior or accidental leaks. All IT systems manage security by monitoring for, and actively reacting to, security being compromised. We included monitoring as essential part of a secure cloud. Being able to react in a timely manner to data leaks may require additional methods, such as integration with third-party solution providers (e.g., http://www.splunk.com/en_us/solutions/ solution-areas/security-and-fraud.html) or application of other machine-learning approaches to identify security breaches in near real time.
Privacy researchers have shown 6 that the availability of de-identified partial genomic data can result in patient re-identification through the combination of de-identified data with other public sources and Internet searches. For example, the well-publicized 2013 re-identification of Personal Genome Project participants 7 relied on information derived from publicly accessible profiles: birth date, gender and ZIP (postal) code. Although most re-identification attempts to date have been carried out by experts in an academic setting, there are concerns about privacy leaks if large-scale hacking results in de-identified genomic data falling into the wrong hands. Several studies suggest that algorithmic methods, such as partial homomorphic encryption 8 , secure multiparty computation or differential privacy, can provide the necessary privacy-protecting layer for genomic data. The extent to which these complex The contribution of cell cycle to heterogeneity in single-cell RNA-seq data
npg VOLUME 34 NUMBER 6 JUNE 2016 NATURE BIOTECHNOLOGY latent factor (R 2 = 0.74-0.92). Notably, the variability in geometric size within cell cycle phase is substantial, and it overlaps between cycles, as seen in the PCA plot of mESC cells (Fig. 1) . On the basis of this information, we conclude that the latent factor most directly captures geometric size variability, which happens to be a suitable proxy for cell cycle in the mESC. This suggests an alternative interpretation, that the correlation between the scLVM cell cycle variability and the Hoechst staining ( Supplementary Fig. 8 1 show that total library Recently, we profiled gene expression in 930 cells targeting canonical cell cycle genes ('ranked' genes) and genes without known cell cycle annotation ('unranked' genes) across three cell lines 2 . We estimated that cell cycle explained 17% of the generalized linear model deviance (analogous to ANOVA R 2 ) in the typical ranked gene, and 5% in the typical unranked gene. On the basis of these results, we concluded that cell cycle did not cause substantial variability in single-cell gene expression. Our findings were not concordant with those reported in Buettner et al. 1 , and we therefore sought to explain the discrepancies.
First, we explored the claim by Buettner et al. 1 that cell cycle explains a substantial proportion of the variability in singlecell gene expression. Their gold-standard estimates of cell-cycle-induced variability (R 2 from one-way ANOVA on cell cycle using log expression, shown in Supplementary  Fig. 4b ,d of their paper 1 ) broadly agree with our previous observations 2 . We found that the variability attributable to cell cycle ranges from 3% to 15% (for median to 90 th percentile genes) in the 8,949 unranked genes and from 8% to 26% in the 622 ranked genes. However, the single-cell latent variable model (scLVM) method of Buettner et al. 1 attributes >30% of the variability to its latent factor, which is putatively the cell cycle stage ( Fig. 3 and Supplementary Fig. 21 in the original paper 1 ). We conjectured that the scLVM latent factor would track the principal component of variability in the data, but it was unclear whether cell cycle would be the largest contributor. We therefore explored other covariates that might explain variability in the mouse embryonic stem cell (mESC) and mouse T-cell data sets.
Using principal-component analysis (PCA), we found that the first principal component (PC1) tracked the geometric library size (R 2 > 0.99)-the sum of log expression values over all genes in a celland explained 9% and 29% of expression variance in mESC and T cells, respectively. The substantial influence of geometric library size is expected because Buettner et al. 1 use exogenous spike-ins to normalize for unwanted technical variation in library preparation and sequencing depth. This approach leaves endogenous variation in library size intact, while relying on the assumption that technical variation affects both spike-ins and endogenous transcript uniformly for all genes and read counts. These assumptions have been difficult to verify. A recent paper by Risso et al. 3 reported that External RNA Control Consortium (ERCC) spike-ins led to poorly normalized counts in the context of bulk RNA-seq. Furthermore, a recent paper by Padovan-Merhar and colleagues 4 showed experimentally that single cells compensate for changes in cell volume by increasing transcript abundance. Their work implies that correcting for transcript abundance is important because variability in cell volume may be a substantial source of undesired or uninteresting biological variability. The type of normalization used should depend primarily on the scientific questions considered, so no single scheme will be appropriate for all circumstances. Finding the optimal method for normalization remains a major challenge in the field.
Cell size varies during the cell cycle, and the scLVM factor proxies geometric size (R 2 = 0.92, in both experiments). Although cell cycle can explain 64% of the variance in the scLVM factor, the factor seems to intrinsically restate the geometric size. Within each cell cycle phase, geometric size remains highly correlated to the scLVM 1 also use the scLVM latent factor to derive cell-cycle-adjusted expression values. Another interpretation of these adjusted expression values is that a source of nuisance variability (geometric size differences) has been regressed out. This approach has a long record of successful application in gene-expression experiments 5 . To further elucidate the effect of the scLVM adjustment, we considered gene-set enrichment analysis (GSEA) comparing the two clusters that Buettner et al. 1 identified in the cycle-adjusted T-cell data (corresponding roughly to corrected expression levels of the differentiation factor GATA3). Of the top 20 modules identified as significantly enriched (q-value < 1%) using the Reactome or GO Biological process databases, 15 were directly or indirectly related, via DNA repair or replication pathways, to cell cycle in Reactome (n = 674 modules total), whereas 17 of 20 were related to cell cycle or DNA repair or replication in GO (n = 825 modules total). Although scLVM purports to remove additive cell cycle effects, we conjecture that it is primarily removing geometric size effects, which are a weaker proxy for cell cycle in the T cells than in the mESCs, and that therefore cell cycle was incompletely removed. Moreover, our own analysis of the corrected and uncorrected T-cell data using two common dimensionality reduction techniques failed to find compelling evidence for the existence of these two clusters of cells. Identification of these subpopulations appears to be dependent on the dimensionality reduction technique employed. In general, direct measurement via Hoechst staining could be more appropriate for investigators who require cell cycle as a covariate.
C O R R E S P O N D E N C E
In conclusion, we believe that the data presented by Buettner et al. 1 suggest that cell cycle comprises less than 7% of the variance in the typical (median) gene, and that geometric library size, rather than cell cycle, may better explain the observed variability in gene expression. Consequently, caution may be warranted when using spike-ins for RNA quantification. It would be of interest to investigate what biological factors, besides cell cycle, are associated with the geometric size and how the efficiency of rate-limiting steps (such as lysis and reverse transcription) affect these factors.
We thank Buettner, Natarajan and colleagues for their openness in sharing their data and code, and for their willingness to contribute to this discussion. All code used to produce the results discussed here is available at https://github.com/RGLab/BNCResponse and in the Supplementary Source Code. 
Editor

Buettner, Marioni and Stegle reply:
McDavid et al. 1 raise several interesting points regarding our method to account for heterogeneity in single-cell gene expression. They argue that it is geometric library size and not cell cycle effects that explains the majority of the variation we observe in our RNA sequencing data. They also highlight challenges in using ERCC spike-ins for normalizing sequencing read counts. We agree that the normalization of singlecell RNA-seq data is an important issue that requires careful attention and have acknowledged previous papers highlighting these issues 2,3 . However, we contend that many of the points raised by McDavid et al. were discussed in our original manuscript. Additionally, we disagree with several aspects of their interpretation and analysis.
In our original paper 2 , we showed that the magnitude of the observed cell cycle effect depends on whether cell size (which we define as the number of endogenous mRNA molecules within a cell) has been accounted for (for example, via total count normalization) or not. More specifically, we applied scLVM to data normalized using size factors derived from counts mapped to endogenous genes ( Supplementary Fig.  21 in our paper 2 ) and to FPKM (fragments per kilobase of transcript per million mapped reads)-normalized mESC data from Sasagawa et al. 4 , where the approach used to normalize the raw count data implicitly adjusts for cell size. As expected, normalization strategies that adjust for cell size variability resulted in lower overall estimates of the contribution of cell cycle to total variability in gene expression across cells (Supplementary Figs. 8 and 21 in our  paper 2 ) . Nevertheless, even after regressing out cell size before applying scLVM, we consistently observed good agreement between the variance estimates obtained using Hoechst staining and the scLVM estimates of the variance attributable to the cell cycle ( Supplementary Fig. 8 in our  paper 2 ) . Additionally, we note that the inferred signatures of the cell cycle factor between different datasets (projection of principal component 1 (PC1) and PC2) are robust, irrespective of the normalization employed. These axes of variation are consistent across datasets ( Supplementary  Fig. 10 in our paper 2 ) , further supporting the robustness of our approach.
We considered alternative approaches for estimating size factors to further investigate how well the inferred scLVM factor tracks cell size and other features. In particular, we used a recently proposed Bayesian method, BASiCS 5 , which infers separate size factors corresponding to cell size and technical variation. In Figure 1 , we present correlations between the scLVM factor and the estimated size factors. This analysis reveals that the scLVM factor is moderately correlated with cell size factors (R 2 = 0.74) and shows similar correlations with other computed size factors. This moderate correlation is not surprising because cell size and cell cycle stage are clearly related. McDavid et al. 1 use an unconventional approach to compute a "geometric size factor" that uses only a subset of genes and computes the size factor on the normalized log scale. They observe that this geometric size factor is strongly correlated (R 2 = 0.92) with the scLVM factor and go on to hypothesize that the scLVM factor captures information relating only to cell size. However, the much lower correlation of the scLVM factor with the independently computed normalization in BASiCS, which is explicitly designed to account for variation in cell size, as well as other size factor estimates in common usage, suggests that the scLVM factor does capture
